Tara N. Troy

University of Chicago

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Josh Levitsky

Northwestern University

Thomas W. Faust

University of California, San Francisco

Dezheng Huo

Chicago Department of Public Health

Donald M. Jensen

Rush University Medical Center

Stanley M. Cohen

Case Western Reserve University

Bridget O'Brien

Colorado Kidney Care

John Hart

University of Chicago

Smruti R. Mohanty

Newark Beth Israel Medical Center

Helen S. Te

University of Chicago

Cooperative Institutions

University of Chicago

University of Chicago Medical Center

University of California, San Francisco

Methodist University Hospital

Center for Digestive and Liver Diseases

Methodist Le Bonheur Healthcare

University of Tennessee Health Science Center

Methodist University

MedStar Georgetown University Hospital

Georgetown University

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

RELAPSING HEPATITIS A AS AN INDICATION FOR LIVER TRANSPLANTATION

The American Journal of Gastroenterology (2003)

Tara N. Troy Josh Levitsky Helen S. Te Stanley M. Cohen

s Submitted for the 68th Annual Scientific Meeting of the American College of Gastroenterology October 10-15, 2003, Baltimore, Maryland: CLINICAL VIGNETTES: PDF Only

10.1111/j.1572-0241.2003.08225.x

Cite

Citations (0)

Influence of ethnicity on histological differences in non-alcoholic fatty liver disease

Journal of Hepatology (2009)

Smruti R. Mohanty Tara N. Troy Dezheng Huo Bridget O'Brien Donald M. Jensen

10.1016/j.jhep.2008.11.017

Cite

Citations (141)

Relapsing hepatitis a as an indication for liver transplantation

The American Journal of Gastroenterology (2003)

Tara N. Troy

Estimates of the cost of long-term complications of a primary deep vein thrombosis (DVT), including the post-thrombotic syndrome (PTS) and recurrent venous thromboembolism (VTE), may be relevant for resource allocation decisions.The objective of this study was to provide US cost estimates of the long-term complications of a primary DVT, which occurs in approximately 5% to 20% (with adequate thromboprophylaxis) and 50% (in the absence of thromboprophylaxis) of total hip replacement surgeries (THRS).A literature-based model was used to project the excess long-term complication costs of DVT following THRS. The model simulated the natural history of DVT complications using published estimates of the incidence and prognosis of PTS and recurrent VTE. Each complication was assigned a cost obtained by multiplying the amount of resources used in its management by the unit price of these resources.The annual per-patient cost of each complication was as follows: mild-to-moderate PTS, $839 in the first year and $341 in subsequent years; severe PTS, $3817 in the first year and $1677 in subsequent years; DVT, $3798; and pulmonary embolism, $6604. The average discounted lifetime cost of DVT complications was estimated to be $3069 (95% interval $2091–$4279).The long-term complications of a primary DVT represent a significant economic burden. Preventing a DVT could arguably lead to substantial savings in long-term DVT complications.

Post-thrombotic syndrome

10.1016/s0002-9270(03)01258-9

Cite

Citations (1)

Hepatorenal Syndrome

Elsevier eBooks (2004)

Josh Levitsky Tara N. Troy Thomas W. Faust

10.1016/b0-12-386860-2/00366-x

Cite

Citations (0)